| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049234 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 03/03/2005 | US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides |
| 03/03/2005 | US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048027 Non-neurotoxic plasminogen activating factors for treating stroke |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/02/2005 | EP1510524A2 Compounds and peptides that bind to the erythropoietin receptor |
| 03/02/2005 | EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| 03/02/2005 | EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1510216A1 Antithrombogenic platiniferous ceramic composition and article containing the same |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509516A1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509505A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO |
| 03/02/2005 | EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 03/02/2005 | EP1509241A1 Novel uses of cephaibols |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509231A1 Peritoneal dialysis solution with taurolidine |
| 03/02/2005 | EP1509228A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators |
| 03/02/2005 | EP1509219A1 Methods and compositions for the treatment of graft failure |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589140A Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/02/2005 | CN1589098A Prevention and treatment of diseases associated with blood coagulation |
| 03/02/2005 | CN1586620A Poly gelatin peptide injection and its preparing method |
| 03/02/2005 | CN1586593A Wild chrysanthemum oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586575A Medicine decoction for benifiting qi, tonifying blood and resisting cancer |
| 03/02/2005 | CN1586545A Preparation for treating leukopenia and its preparation |
| 03/02/2005 | CN1586534A Nao'an oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1586484A Dipyridamole soft capsule preparation and its preparing method |
| 03/02/2005 | CN1586475A Vitamin C oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586473A Daphnetic soft capsule and its preparing method |
| 03/02/2005 | CN1586467A Troxerutin powder injection |
| 03/02/2005 | CN1191360C Modified clotting factor VIII |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861519 Soluble highly branched glucose polymers and their method of production |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861407 Methods of therapy with thrombin derived peptides |
| 03/01/2005 | US6861054 suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 02/24/2005 | WO2005017139A1 Thrombin from venom of agkistrodon acutus used as drugs for the treatment of haemorrhage |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016455A2 Antibodies against factor viii with modified glycosylation in the variable region |
| 02/24/2005 | WO2005007183A3 Treatment of anemia |
| 02/24/2005 | WO2004113363A3 Dipeptide transglutaminase inhibitors and methods of using the same |
| 02/24/2005 | US20050043788 Drug-eluting stent |
| 02/24/2005 | US20050043413 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043375 Solid preparation containing single crystal form |
| 02/24/2005 | US20050043362 Use of compounds |
| 02/24/2005 | US20050043355 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043303 prophylaxis of cardiovascular disorders comprising administering to mammals inhibitors of cyclic guanosine monophosphate metabolizing phosphodiesterases such as 2-{2-Ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulfonyl]-phenyl}-6-methyl-8-propyl-3H-imidazo[1,5-a][1,3,5]triazin-4-one; antiarrythmic agents |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042733 Propagating swine mast cells in nutrient broth and recovering mucopolysaccharides/heparin |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | DE102004010545A1 Pyrazoline Pyrazolines |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535489A1 Antibodies against factor viii with modified glycosylation in the variable region |
| 02/23/2005 | EP1508561A1 2-(a-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507764A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507559A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1583777A Long-noded pit viper dissolving fiber protein No.4 gene and use thereof |